InvestorsHub Logo
Replies to #81305 on Biotech Values
icon url

north40000

07/23/09 2:46 PM

#81311 RE: DewDiligence #81305

MEDX-BMY deal likely etched in stone???

I do not agree with either of you.

Not so long ago BMY made another low-ball offer, this time for IMCL @ $60/share. Agreements by BODs were in place.

Something happened, and BMY raised its offer to $64/share if I recall correctly. Then LLY comes along[perhaps courtesy of activist Carl Icahn] and makes an offer of $70/share. Miracle happened, and IMCL accepted that offer.

Carl Icahn and his business funds are[at last word that I have] also invested in MEDX. Who knows what may happen---I don't.

One thing for sure...the non-solicitation clause supposedly in the MEDX/BMY agreement is not going to prevent a 3rd party that has >$ 2.4 billion from making an offer if it so chooses.
$3-4 billion might just do it. Not much money, IMO, for that
pipeline and personnel:

http://www.medarex.com/Development/Pipeline.htm